Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 205.80
-5.40 (-2.56%)
Jan 21, 2026, 12:48 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 6.65 billion as of January 21, 2026. Its market cap has decreased by -56.81% in one year.
Market Cap
6.65B
Enterprise Value
6.50B
Revenue
813.59M
Ranking
n/a
PE Ratio
222.49
Stock Price
205.80
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 6.65B, an increase of 1,689.84%. That is a compound annual growth rate of 24.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 6.65B | 13.18% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.19B |
| Getinge AB | 57.85B |
| BioArctic AB | 46.50B |
| Sectra AB | 43.27B |
| Camurus AB | 39.51B |
| Medicover AB | 30.95B |
| Asker Healthcare Group AB | 29.69B |
| Elekta AB | 23.31B |